Elias Aboujaoude, MD, MA
Publication Details
-
Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder.
J Clin Psychiatry. 2005; (3): 353-9
Obsessive-compulsive disorder (OCD) often responds inadequately to serotonin reuptake inhibitors (SRIs). A case series reported substantial response to once-weekly oral morphine. We conducted a placebo-controlled, double-blind trial to investigate whether once-weekly oral morphine is effective in SRI-resistant OCD.
